NXTC
NextCure
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- NextCure received FDA Fast Track designation for SIM0505 in ovarian cancerApr 7, 2026
- NextCure announces $21.5 million private placement of common stock priced at the market under Nasdaq rulesNov 12, 2025
- NextCure and Simcere Zaiming announce expansion of ongoing Phase 1 trial of SIM0505 (CDH6 ADC) into the United StatesOct 16, 2025
- NextCure and Simcere Zaiming announce partnership for novel antibody-drug conjugate targeting CDH6Jun 16, 2025